Biological Imaging Reagents Market

Biological Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents, and Nuclear Agents; and Modality: MRI, Ultrasound, X-Ray & CT, Nuclear, Optical Imaging, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Biological Imaging Reagents Market Outlook 2031

  • The global industry was valued at US$ 16.8 Bn in 2022
  • It is expected to grow at a CAGR of 5.4% from 2023 to 2031 and reach US$ 26.9 Bn by the end of 2031

Analyst Viewpoint

Rise in adoption of multimodal imaging is a prominent factor boosting the global biological imaging reagents industry size. Multimodal imaging lowers the detection threshold of an independent technique with the higher detection threshold of the other independent technique to provide better scanning outcome.

Extensive research in usage of quantum physics to enable better detection is one of the key biological imaging reagents market trends.

Companies operating in the global biological imaging reagents market are pairing radionuclides for diagnostic and therapeutic applications to add to the existing methods of radiolabeling and separation.

They are also supplying a suite of cell function kits that help visualize key cellular events including apoptosis, viability, mitochondrial membrane potential, and indicators for calcium, hypoxia, or reactive oxygen species (ROS).

Market Introduction

Biological imaging reagents help detect biological processes at molecular level and enable medical physicians/practitioners to obtain diagnostic information to detect and treat diseases, especially in neurology, cardiology, and oncology fields.

Types of biological imaging reagents include fluorescent proteins, fluorescent probes and dyes, nanoparticles, ultrasound and x-ray contrast reagents, MRI, and imaging radiopharmaceuticals.

Advantages of biological imaging reagents include higher sensitivity, multicolor capability, unlimited tissue penetration, and high spatial resolution.

However, high cost of these cell staining and labeling reagents is restraining the biological imaging reagents market growth to a certain extent. Dearth of skilled healthcare professionals is another factor hampering market progress.

Attribute Detail
Market Drivers
  • Growth in Adoption of Multimodal Imaging
  • Rise in Demand for Diagnostic Imaging Devices

Rise in Adoption of Multimodal Imaging Augmenting Biological Imaging Reagents Market Revenue

Multimodal imaging, also known as multiplexed imaging, is increasingly being used in identification and treatment of several chronic diseases such as cancers, cardiovascular disorders, ophthalmic disorders, and neurological diseases.

Multimodal imaging techniques such as PET/MRI, PET/CT, and SPECT/CT enable better detection of anatomic, pathophysiological, and molecular changes in single scan that involves administration of radiolabeled peptide probes.

Currently, multimodality studies use hybrid magnetic-fluorescent QD nanoparticles to detect tumors through fluorescent imaging and MRI, thereby allowing for an increase in anatomic information through enhanced resolution.

Growth in prevalence of Chronic Obstructive Pulmonary Disorders (COPDs) is a major factor that is driving the adoption of multimodal imaging techniques worldwide. As per the WHO, COPD is one of leading causes of morbidity and mortality across the globe.

Increase in Demand for Diagnostic Imaging Devices

As per GE Healthcare, more than 95 million MRI scans are performed every year at the global level. Biological imaging reagents improve upon visibility of structures that MRI picks up.

Research states that fluorescence-based assays, in conjunction with microscopy, render mechanistic details that their counterparts do not. For instance, the size of glucosome and cytoplasmic enzyme assemblies for metabolism of glucose are modulated in various cell cycle stages for regulating glucose flux between building-block biosynthesis and glycolysis.

Better entailing of these intricacies is driving the fluorescent biological imaging agents market. Healthcare personnel are moving toward bioluminescent imaging probes from the conventional methods in light of benefits such as better luminosity.

Thus, rise in demand for diagnostic imaging devices such as x-ray devices and MRI along with implementation of PACS (Picture Archiving and Communication Systems) is bolstering the biological imaging reagents market.

Regional Outlook

Attribute Detail
Leading Region North America

As per the latest biological imaging reagents market analysis, North America accounted for the largest share of the global landscape in 2022. The region is expected to maintain its leading position during the forecast period.

High biological imaging reagents market share of North America can be ascribed to the increase in adoption of advanced technologies, such as Artificial Intelligence (AI), in molecular imaging and rise in awareness regarding detection/diagnosis at an early stage in the region.

Europe also recorded significant market expansion in 2022. This can be ascribed to the high number of tests being performed and availability of strong healthcare infrastructure in the region.

Biological imaging reagents market forecast in Asia Pacific and Latin America appears positive owing to the growth in healthcare infrastructure and rise in emphasis on R&D activities in imaging techniques in the region.

Analysis of Key Players

Companies operating in the global biological imaging reagents landscape are providing new clinical data for contrast agents in order to introduce reagents with better imaging capacities.

For instance, Thermo Fisher Inc.’s ReadyProbes reagents are ready-to-use imaging solutions that allow staining of cells with no dilutions, calculations, and pipetting.

Leading market players are engaged in new product launches and extensive R&D activities in biological imaging reagents to expand their global reach. For instance, Bayer AG has entered into a partnership with radiology AI providers such as Imagine Software, Qure.ai, Brainomix Limited, and Perspectum Limited to expand its offerings on the Calantic medical imaging platform.

Bayer AG, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Guerbet, Lantheus Holdings, Inc., Bracco S.p.A., GE Healthcare, Becton, Dickinson and Company (BD), Siemens Healthineers, and Luminex Corporation are the key players that have been profiled in the biological imaging reagents market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Key Development in Biological Imaging Reagents Industry

  • In September 2023, Revvity, Inc. launched the next-generation IVIS SpectrumCT 2 and IVIS Spectrum 2 imaging systems with the objective of inducing a higher level of sensitivity and versatility standards in in-vivo optical imaging

Biological Imaging Reagents Market Snapshot

Attribute Detail
Market Size in 2022 US$ 16.8 Bn
Market Forecast (Value) in 2031 US$ 26.9 Bn
Growth Rate (CAGR) 5.4%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Class
    • Contrast Reagents
    • Optical Agents
    • Nuclear Agents
  • Modality
    • MRI
    • Ultrasound
    • X-Ray & CT
    • Nuclear
      • PET
      • SPECT
    • Optical Imaging
    • Others
  • Application
    • In Vitro
      • Proteomics
      • Genomics
      • Cell Biology
    • In Vivo
  • End-user
    • Diagnostic Laboratories
    • Life Science Companies
    • Imaging Centers
    • Academic & Research Institutes
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Bayer AG
  • Thermo Fisher Scientific, Inc.
  • PerkinElmer, Inc.
  • Guerbet
  • Lantheus Holdings, Inc.
  • Bracco S.p.A.
  • GE Healthcare
  • Becton, Dickinson and Company (BD)
  • Siemens Healthineers
  • Luminex Corporation
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global biological imaging reagents market in 2022?

It was valued at US$ 16.8 Bn in 2022

How is the biological imaging reagents business expected to grow during the forecast period?

It is projected to grow at a CAGR of 5.4% from 2023 to 2031

What are the key factors driving the demand for biological imaging reagents?

Growth in adoption of multimodal imaging and rise in demand for diagnostic imaging devices

Which biological imaging reagents end-user segment held the largest share in 2022?

The diagnostic laboratories segment accounted for the largest share in 2022

Which region dominated the global biological imaging reagents landscape in 2022?

North America was the dominant region in 2022

Who are the key biological imaging reagents manufacturers?

Bayer AG, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Guerbet, Lantheus Holdings, Inc., Bracco S.p.A., GE Healthcare, Becton, Dickinson and Company (BD), Siemens Healthineers, and Luminex Corporation

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Biological Imaging Reagents Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Class, 2017–2031

            6.3.1. Contrast Agents

            6.3.2. Optical Reagents

            6.3.3. Nuclear Agents

        6.4. Market Attractiveness, by Class

    7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Modality, 2017–2031

            7.3.1. MRI

            7.3.2. Ultrasound

            7.3.3. X-Ray & CT

            7.3.4. Nuclear

                7.3.4.1. PET

                7.3.4.2. SPECT

            7.3.5. Optical Imaging

            7.3.6. Others

            7.3.7. 7.4 Market Attractiveness, by Modality

    8. Global Biological Imaging Reagents Market Analysis and Forecast, By Application

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, By Application, 2017–2031

            8.3.1. In Vitro

                8.3.1.1. Proteomics

                8.3.1.2. Genomics

                8.3.1.3. Cell Biology

            8.3.2. In Vivo

        8.4. Market Attractiveness, By Application

    9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user

        9.1. Introduction and Definitions

        9.2. Key Findings/Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Diagnostic Laboratories

            9.3.2. Life Science Companies

            9.3.3. Imaging Centers

            9.3.4. Academic & Research Institutes

            9.3.5. Others

        9.4. Market Attractiveness, by End-user

    10. Global Biological Imaging Reagents Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region, 2017–2031

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness, by Region

    11. North America Biological Imaging Reagents Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Class, 2017–2031

            11.2.1. Contrast Agents

            11.2.2. Optical Reagents

            11.2.3. Nuclear Agents

        11.3. Market Attractiveness, by Class

        11.4. Market Value Forecast, by Modality, 2017–2031

            11.4.1. MRI

            11.4.2. Ultrasound

            11.4.3. X-Ray & CT

            11.4.4. Nuclear

                11.4.4.1. PET

                11.4.4.2. SPECT

            11.4.5. Optical Imaging

            11.4.6. Others

        11.5. Market Attractiveness, by Modality

        11.6. Market Value Forecast, By Application, 2017–2031

            11.6.1. In Vitro

                11.6.1.1. Proteomics

                11.6.1.2. Genomics

                11.6.1.3. Cell Biology

            11.6.2. In Vivo

        11.7. Market Attractiveness, By Application

        11.8. Market Value Forecast, by End-user, 2017–2031

            11.8.1. Diagnostic Laboratories

            11.8.2. Life Science Companies

            11.8.3. Imaging Centers

            11.8.4. Academic & Research Institutes

            11.8.5. Others

        11.9. Market Attractiveness, by End-user

        11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.10.1. U.S.

            11.10.2. Canada

        11.11. Market Attractiveness Analysis

            11.11.1. By Class

            11.11.2. By Modality

            11.11.3. By Application

            11.11.4. By End-user

            11.11.5. By Country

    12. Europe Biological Imaging Reagents Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Class, 2017–2031

            12.2.1. Contrast Agents

            12.2.2. Optical Reagents

            12.2.3. Nuclear Agents

        12.3. Market Attractiveness, by Class

        12.4. Market Value Forecast, by Modality, 2017–2031

            12.4.1. MRI

            12.4.2. Ultrasound

            12.4.3. X-Ray & CT

            12.4.4. Nuclear

                12.4.4.1. PET

                12.4.4.2. SPECT

            12.4.5. Optical Imaging

            12.4.6. Others

        12.5. Market Attractiveness, by Modality

        12.6. Market Value Forecast, By Application, 2017–2031

            12.6.1. In Vitro

                12.6.1.1. Proteomics

                12.6.1.2. Genomics

                12.6.1.3. Cell Biology

            12.6.2. In Vivo

        12.7. Market Attractiveness, By Application

        12.8. Market Value Forecast, by End-user, 2017–2031

            12.8.1. Diagnostic Laboratories

            12.8.2. Life Science Companies

            12.8.3. Imaging Centers

            12.8.4. Academic & Research Institutes

            12.8.5. Others

        12.9. Market Attractiveness, by End-user

        12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.10.1. Germany

            12.10.2. U.K.

            12.10.3. France

            12.10.4. Italy

            12.10.5. Spain

            12.10.6. Rest of Europe

        12.11. Market Attractiveness Analysis

            12.11.1. By Class

            12.11.2. By Modality

            12.11.3. By Application

            12.11.4. By End-user

            12.11.5. By Country/Sub-region

    13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Class, 2017–2031

            13.2.1. Contrast Agents

            13.2.2. Optical Reagents

            13.2.3. Nuclear Agents

        13.3. Market Attractiveness, by Class

        13.4. Market Value Forecast, by Modality, 2017–2031

            13.4.1. MRI

            13.4.2. Ultrasound

            13.4.3. X-Ray & CT

            13.4.4. Nuclear

                13.4.4.1. PET

                13.4.4.2. SPECT

            13.4.5. Optical Imaging

            13.4.6. Others

        13.5. Market Attractiveness, by Modality

        13.6. Market Value Forecast, By Application, 2017–2031

            13.6.1. In Vitro

                13.6.1.1. Proteomics

                13.6.1.2. Genomics

                13.6.1.3. Cell Biology

            13.6.2. In Vivo

        13.7. Market Attractiveness, By Application

        13.8. Market Value Forecast, by End-user, 2017–2031

            13.8.1. Diagnostic Laboratories

            13.8.2. Life Science Companies

            13.8.3. Imaging Centers

            13.8.4. Academic & Research Institutes

            13.8.5. Others

        13.9. Market Attractiveness, by End-user

        13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.10.1. China

            13.10.2. Japan

            13.10.3. India

            13.10.4. Australia & New Zealand

            13.10.5. Rest of Asia Pacific

        13.11. Market Attractiveness Analysis

            13.11.1. By Class

            13.11.2. By Modality

            13.11.3. By Application

            13.11.4. By End-user

            13.11.5. By Country/Sub-region

    14. Latin America Biological Imaging Reagents Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Class, 2017–2031

            14.2.1. Contrast Agents

            14.2.2. Optical Reagents

            14.2.3. Nuclear Agents

        14.3. Market Attractiveness, by Class

        14.4. Market Value Forecast, by Modality, 2017–2031

            14.4.1. MRI

            14.4.2. Ultrasound

            14.4.3. X-Ray & CT

            14.4.4. Nuclear

                14.4.4.1. PET

                14.4.4.2. SPECT

            14.4.5. Optical Imaging

            14.4.6. Others

        14.5. Market Attractiveness, by Modality

        14.6. Market Value Forecast, By Application, 2017–2031

            14.6.1. In Vitro

                14.6.1.1. Proteomics

                14.6.1.2. Genomics

                14.6.1.3. Cell Biology

            14.6.2. In Vivo

        14.7. Market Attractiveness, By Application

        14.8. Market Value Forecast, by End-user, 2017–2031

            14.8.1. Diagnostic Laboratories

            14.8.2. Life Science Companies

            14.8.3. Imaging Centers

            14.8.4. Academic & Research Institutes

            14.8.5. Others

        14.9. Market Attractiveness, by End-user

        14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.10.1. Brazil

            14.10.2. Mexico

            14.10.3. Rest of Latin America

        14.11. Market Attractiveness Analysis

            14.11.1. By Class

            14.11.2. By Modality

            14.11.3. By Application

            14.11.4. By End-user

            14.11.5. By Country/Sub-region

    15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Class, 2017–2031

            15.2.1. Contrast Agents

            15.2.2. Optical Reagents

            15.2.3. Nuclear Agents

        15.3. Market Attractiveness, by Class

        15.4. Market Value Forecast, by Modality, 2017–2031

            15.4.1. MRI

            15.4.2. Ultrasound

            15.4.3. X-Ray & CT

            15.4.4. Nuclear

                15.4.4.1. PET

                15.4.4.2. SPECT

            15.4.5. Optical Imaging

            15.4.6. Others

        15.5. Market Attractiveness, by Modality

        15.6. Market Value Forecast, By Application, 2017–2031

            15.6.1. In Vitro

                15.6.1.1. Proteomics

                15.6.1.2. Genomics

                15.6.1.3. Cell Biology

            15.6.2. In Vivo

        15.7. Market Attractiveness, By Application

        15.8. Market Value Forecast, by End-user, 2017–2031

            15.8.1. Diagnostic Laboratories

            15.8.2. Life Science Companies

            15.8.3. Imaging Centers

            15.8.4. Academic & Research Institutes

            15.8.5. Others

        15.9. Market Attractiveness, by End-user

        15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.10.1. GCC Countries

            15.10.2. South Africa

            15.10.3. Rest of Middle East & Africa

        15.11. Market Attractiveness Analysis

            15.11.1. By Class

            15.11.2. By Modality

            15.11.3. By Application

            15.11.4. By End-user

            15.11.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player – Competition Matrix (By Tier and Size of Companies)

        16.2. Market Share Analysis, by Company (2022)

        16.3. Company Profiles

            16.3.1. Bayer AG

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. Financial Overview

                16.3.1.4. SWOT Analysis

                16.3.1.5. Strategic Overview

            16.3.2. Thermo Fisher Scientific, Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. PerkinElmer, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. Financial Overview

                16.3.3.4. SWOT Analysis

                16.3.3.5. Strategic Overview

            16.3.4. Guerbet

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. Lantheus Holdings, Inc.

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Bracco S.p.A.

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. Financial Overview

                16.3.6.4. SWOT Analysis

                16.3.6.5. Strategic Overview

            16.3.7. GE Healthcare

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Becton, Dickinson and Company (BD)

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. Siemens Healthineers

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. Financial Overview

                16.3.9.4. SWOT Analysis

                16.3.9.5. Strategic Overview

            16.3.10. Luminex Corporation

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. Financial Overview

                16.3.10.4. SWOT Analysis

                16.3.10.5. Strategic Overview

    List of Tables

    Table 01: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 02: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 03: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017–2031

    Table 04: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 05: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 06: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 08: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 09: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017–2031

    Table 10: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017–2031

    Table 11: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 12: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 13: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 14: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 15: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 16: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 17: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 19: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    Table 20: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 21: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031

    Table 22: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031

    List of Figures

    Figure 01: Global Biological Imaging Reagents Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Class, 2022

    Figure 03: Global Biological Imaging Reagents Market Value Share, by Class, 2022

    Figure 04: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Modality, 2022

    Figure 05: Global Biological Imaging Reagents Market Value Share, by Modality, 2022

    Figure 06: Global Biological Imaging Reagents Market Revenue (US$ Mn), By Application, 2022

    Figure 07: Global Biological Imaging Reagents Market Value Share, By Application, 2022

    Figure 08: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, 2017–2031

    Figure 09: Global Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 10: Global Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031

    Figure 11: Global Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 12: Global Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 13: Global Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031

    Figure 14: Global Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031

    Figure 15: Global Biological Imaging Reagents Market Attractiveness Analysis, by Region, 2023–2031

    Figure 16: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 17: North America Biological Imaging Reagents Market Attractiveness Analysis, by Country, 2023–2031

    Figure 18: North America Biological Imaging Reagents Market Value Share Analysis, by Country, 2022–2031

    Figure 19: North America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 20: North America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 21: North America Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031

    Figure 22: North America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 23: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 24: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 25: Europe Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 26: Europe Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 27: Europe Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 28: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031

    Figure 29: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 30: Europe Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031

    Figure 31: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 32: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 33: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 34: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 35: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031

    Figure 36: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 37: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 38: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 39: Latin America Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 40: Latin America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 41: Latin America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 42: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031

    Figure 43: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 44: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 45: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 46: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 47: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031

    Figure 48: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031

    Figure 49: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031

    Figure 50: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by End-user, 2022–2031

    Figure 51: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031

    Figure 52: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031

    Figure 53: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031

    Figure 54: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved